These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32622691)

  • 21. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
    Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
    Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial.
    Kunneman M; Branda ME; Noseworthy PA; Linzer M; Burnett B; Dick S; Spencer-Bonilla G; Fernandez CA; Gorr H; Wambua M; Keune S; Zeballos-Palacios C; Hargraves I; Shah ND; Montori VM
    Trials; 2017 Sep; 18(1):443. PubMed ID: 28962662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study.
    Maura G; Pariente A; Alla F; Billionnet C
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1367-1377. PubMed ID: 28752560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mental health conditions and adherence to direct oral anticoagulants in patients with incident atrial fibrillation: A nationwide cohort study.
    Teppo K; Jaakkola J; Airaksinen KEJ; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Hartikainen J; Luojus A; Niemi M; Linna M; Lehto M
    Gen Hosp Psychiatry; 2022; 74():88-93. PubMed ID: 34999528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study).
    Dietrich F; Polymeris AA; Albert V; Engelter ST; Hersberger KE; Schaedelin S; Lyrer PA; Arnet I
    J Neurol; 2024 Feb; 271(2):841-851. PubMed ID: 37831125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Guideline-Policy Gap in Direct-Acting Oral Anticoagulants Usage in Atrial Fibrillation: Evidence, Practice, and Public Policy Considerations.
    Wan D; Healey JS; Simpson CS
    Can J Cardiol; 2018 Nov; 34(11):1412-1425. PubMed ID: 30404747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
    J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oral anticoagulants adherence in elderly patients treated for atrial fibrillation in the era of direct oral anticoagulants].
    Drouin L; Gegu M; Mahe J; de Decker L; Berrut G; Chevalet P
    Ann Cardiol Angeiol (Paris); 2017 Sep; 66(4):197-203. PubMed ID: 28506577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases.
    Huiart L; Ferdynus C; Renoux C; Beaugrand A; Lafarge S; Bruneau L; Suissa S; Maillard O; Ranouil X
    BMJ Open; 2018 Mar; 8(3):e018180. PubMed ID: 29602837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the COVID-19 lockdown on the adherence of stroke patients to direct oral anticoagulants: a secondary analysis from the MAAESTRO study.
    Dietrich F; Polymeris AA; Verbeek M; Engelter ST; Hersberger KE; Schaedelin S; Arnet I; Lyrer PA
    J Neurol; 2022 Jan; 269(1):19-25. PubMed ID: 34081196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in anticoagulant prescribing: a review of local policies in English primary care.
    Ho KH; van Hove M; Leng G
    BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type and doses of oral anticoagulants and adherence to anticoagulant treatment in elderly patients with atrial fibrillation: the ESPARTA study.
    Mostaza JM; Suárez Fernández C; Castilla Guerra L; Suriñach JM; Tamarit JJ; Diaz Diaz JL; García Polo I; Santamaria EF; Fidalgo Fernández MA; de la Guerra Acebal C; Dávila Ramos MF; Ràfols C
    J Comp Eff Res; 2018 Mar; 7(3):223-232. PubMed ID: 29465254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining Adherence to Medication in Patients With Atrial Fibrillation: The Role of Medication Beliefs, Attitudes, and Depression.
    Taylor EC; O'Neill M; Hughes LD; Bennett P; Moss-Morris R
    J Cardiovasc Nurs; 2020; 35(4):337-346. PubMed ID: 32084080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.
    Feldman DN; Wang TY; Chen AY; Swaminathan RV; Kim LK; Wong SC; Minutello RM; Bergman G; Singh HS; Madias C
    J Am Heart Assoc; 2019 Apr; 8(8):e011606. PubMed ID: 30955406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysis.
    You JH
    Pharmacogenomics; 2015; 16(10):1089-100. PubMed ID: 26230572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differences in the management of patients with atrial fibrillation according to whether primary care or the specialist initiates treatment with direct oral anticoagulants. The SILVER-AP and BRONCE-AP studies].
    de la Figuera M; Prieto MA; Marín N; Egocheaga I; Cinza S;
    Semergen; 2018; 44(5):323-334. PubMed ID: 29174522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shared decision-making tool for thromboprophylaxis in atrial fibrillation - A feasibility study.
    Eckman MH; Costea A; Attari M; Munjal J; Wise RE; Knochelmann C; Flaherty ML; Baker P; Ireton R; Harnett BM; Leonard AC; Steen D; Rose A; Kues J
    Am Heart J; 2018 May; 199():13-21. PubMed ID: 29754650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study.
    Liu T; Yang HL; Gu L; Hui J; Omorogieva O; Ren MX; Wang XH
    BMC Cardiovasc Disord; 2020 Jan; 20(1):22. PubMed ID: 31948390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of health literacy and adherence to oral anticoagulation therapy in patients with atrial fibrillation: a cross-sectional study.
    Bartolazzi F; Ribeiro ALP; de Sousa WJFN; Vianna MS; da Silva JLP; Martins MAP
    J Thromb Thrombolysis; 2021 Nov; 52(4):1074-1080. PubMed ID: 33855686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision-making about the use of non-vitamin K oral anticoagulant therapies for patients with atrial fibrillation.
    Eckman MH
    J Thromb Thrombolysis; 2016 Feb; 41(2):234-40. PubMed ID: 26343041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.